Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade

被引:73
作者
Maher, EA
Shepherd, FA
Todd, TJR
机构
[1] TORONTO GEN HOSP,DEPT MED,DIV HEMATOL ONCOL,TORONTO,ON M5G 2C4,CANADA
[2] TORONTO GEN HOSP,DEPT SURG,DIV THORAC SURG,TORONTO,ON M5G 2C4,CANADA
[3] UNIV TORONTO,TORONTO,ON M5S 1A1,CANADA
关键词
D O I
10.1016/S0022-5223(96)70046-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The management of malignant pericardial effusion remains controversial, We present our experience with 93 patients referred for drainage and sclerosing procedures between 1979 and 1994, Methods: With continuous electrocardiographic monitoring, a Kifa catheter was inserted percutaneously into the pericardial sac and allowed to drain, A 100 mg dose of lidocaine hydrochloride was instilled intrapericardially, followed by 500 to 1000 mg tetracycline or doxycycline hydrochloride in 20 to 50 mi normal saline solution, The catheter was clamped for 1 to 2 hours and then reopened, and the procedure was repeated daily until the net drainage was less than 25 mi in 24 hours, Results: Subjects included 53 women and 40 men (median age 58 years), Eight patients could not undergo sclerosis because of technical failure, Eighty-five patients underwent sclerosis and required a median dose of 1500 mg of the sclerosing agent (range 500 to 700 mg), given in a median of three injections (range one to eight), Complications included pain (17 patients), atrial arrhythmias (eight patients), fever with temperature greater than 38.5 degrees C (seven patients), and infection (one patient), Two patients had cardiac arrest before sclerosis could be attempted, Sixty-eight patients (73%) had the effusion controlled for longer than 30 days, for an overall control rate of 81%, Seven other patients had control of the effusion but died of progressive malignant disease in less than 30 days, The overall median survival was 98 days (range 1 to 1724 days), Comparison of these results with outcomes reported for patients with malignant pericardial effusion who underwent surgical drainage indicates that drainage and sclerosis provide similar survivals but sclerosis carries lower morbidity, mortality, and recurrence rates, Conclusion: Percutaneous drainage and sclerosis constitutes a safe and effective treatment for malignant pericardial effusion, Surgical management should be reserved for the small percentage of cases that cannot be controlled by this method.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 41 条
[1]   THE MANAGEMENT OF CARDIAC-TAMPONADE IN PATIENTS WITH BREAST-CANCER [J].
BITRAN, JD ;
EVANS, R ;
BROWN, C .
JOURNAL OF SURGICAL ONCOLOGY, 1984, 27 (01) :42-44
[2]   SUBXIPHOID PERICARDIOTOMY IN THE DIAGNOSIS AND MANAGEMENT OF LARGE PERICARDIAL-EFFUSIONS ASSOCIATED WITH MALIGNANCY [J].
CAMPBELL, PT ;
VANTRIGT, P ;
WALL, TC ;
KENNEY, RT ;
OCONNOR, CM ;
SHEIKH, KH ;
KISSLO, JA ;
BAKER, ME ;
COREY, GR .
CHEST, 1992, 101 (04) :938-943
[3]   THORACOSCOPIC PERICARDIAL FENESTRATION - DIAGNOSTIC AND THERAPEUTIC ASPECTS [J].
CANTO, A ;
GUIJARRO, R ;
ARNAU, A ;
FERNANDEZCENTENO, A ;
CISCAR, MA ;
GALBIS, J ;
GARCIAVILANOVA, A .
THORAX, 1993, 48 (11) :1178-1180
[4]   PERICARDIOCENTESIS FOR SYMPTOMATIC MALIGNANT PERICARDIAL-EFFUSION - A STUDY OF 3L PATIENTS [J].
CELERMAJER, DS ;
BOYER, MJ ;
BAILEY, BP ;
TATTERSALL, MHN .
MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (01) :19-22
[5]  
CHAN A, 1991, CANCER, V68, P1021, DOI 10.1002/1097-0142(19910901)68:5<1021::AID-CNCR2820680519>3.0.CO
[6]  
2-6
[7]   INTRAPERICARDIAL TETRACYCLINE SCLEROSIS IN THE TREATMENT OF MALIGNANT PERICARDIAL-EFFUSION - AN ANALYSIS OF 33 CASES [J].
DAVIS, S ;
RAMBOTTI, P ;
GRIGNANI, F .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :631-636
[8]   CYTOLOGIC ANALYSIS OF PERICARDIAL-EFFUSION COMPLICATING EXTRACARDIAC MALIGNANCY [J].
EDOUTE, Y ;
MALBERGER, E ;
KUTEN, A ;
BENHAIM, SA ;
MOSCOVITZ, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (05) :568-571
[9]  
FRASER RS, 1980, CANCER, V45, P1697, DOI 10.1002/1097-0142(19800401)45:7<1697::AID-CNCR2820450730>3.0.CO
[10]  
2-J